Industrieforen
| Mittwoch, 02.06.2010 | ||
| 13:15-14:15 Raum Montreal | Industrieforum - organisiert durch Biogen-Dompé AG und Pfizer AG Colloque de l‘industrie - organisé par Biogen-Dompé SA et Pfizer SA Controversies in Neurology Chair: H. Mattle, Bern; Switzerland | |
| 13:15-13:25 | Treatment of trigeminal neuralgia Microvascular decompression is the first line treatment V. Rohde, Göttingen; Germany | |
| 13:25-13:35 | Pharmacological and percutaneous methods should be used first P. Sandor, Zurich; Switzerland | |
| 13:35-13:45 | Discussion | |
| 13:45-13:55 | Management of multiple sclerosis Interferons and glatiramer acetate are effective and safe Ch. Kamm, Bern; Switzerland | |
| 13:55-14:05 | There are more effective newer drugs L. Airas, Turku; Finland | |
| 14:05-14:15 | Discussion and Closure | |
 | ||
| Donnerstag, 03.06.2010 | ||
| 12:15-13:15 Raum Montreal | Lunch Symposium - organisiert durch Merck Serono Colloque de l‘industrie - organisé par Merck Serono Advancing the options in MS: a patient focused approach Chair: J. Kesselring, Valens, M. Schluep, Lausanne | |
| 12:15-12:20 | Introduction J. Kesselring, Valens | |
| 12:20-12:45 | Current developments in the field of oral MS therapies P. Rieckmann, Bamberg (Germany) | |
| 12:45-13:05 | Improving convenience and adherence through innovation A. Bayas, Augsburg (Germany) | |
| 12:45-13:05 | Discussion | |
| 13:05-13:10 | Closing remarks M. Schluep, Lausanne | |
| | ||
| Freitag, 04.06.2010 | ||
| 12:15-13:15 Raum Montreal | Industrieforum - organisiert durch UCB Pharma AG Colloque de l‘industrie - organisé par UCB Pharma SA Pharmacological management of epilepsy: issues and hope Chairman: A. Rossetti, Lausanne | |
| 12:15-12:20 | Welcome & Introduction A. Rossetti, Lausanne | |
| 12:20-12:45 | AED in monotherapy: Hope for the best, but be prepared for the worst M. Carreño, Barcelona | |
| 12:45-13:10 | Add-on-treatment of refractory epilepsy: Nihilism can be challenged with success S. Shorvon, London | |
| 13:10-13:15 | Closing Remarks A. Rossetti, Lausanne | |
| | ||
| 17:15-18:15 Raum Montreal | Industrieforum - organisiert durch Novartis Pharma Schweiz AG Colloque de l‘industrie - organisé par Novartis Pharma Schweiz AG Symposium: Opening a new path in MS treatment Chair: Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 17:15-17:20 | Introduction Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 17:20-17:35 | Challenges in MS therapy PD Dr. med. Myriam Schluep, University Hospital Lausanne | |
| 17:35-17:50 | New treatment approach in MS: an oral S1P receptor modulator PD Dr. med. Michael Linnebank, University Hospital Zurich | |
| 17:50-18:10 | Efficacy and safety of an oral S1P receptor modulator Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| 18:10-18:15 | Questions & Answers All Speakers Closing Remarks Prof. Dr. med. Ludwig Kappos, University Hospital Basel | |
| | ||